This topic contains a solution. Click here to go to the answer

Author Question: If the marginal total cost when moving from Option A to Option B is negative and the marginal total ... (Read 83 times)

amal

  • Hero Member
  • *****
  • Posts: 572
If the marginal total cost when moving from Option A to Option B is negative and the marginal total cost when moving from Option B to A is positive, which of the two options is better? What is the underlying principal behind the decision?
 
  What will be an ideal response?

Question 2

In 2010 the family mean income of householders aged 15-24 years was approximately
 
  A) 11,000.
  B) 21,000.
  C) 31,000.
  D) 41,000.
  E) 51,000.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

kbennett34

  • Sr. Member
  • ****
  • Posts: 333
Answer to Question 1

A negative marginal total cost implies that the decision maker is gaining from the switch between options. A positive marginal cost implies that the decision maker is losing from the switch between options. In this case, moving to Option B makes the decision maker better off, while moving away from it makes the decision maker worse off. Hence, Option B is better of the two. The underlying principal behind this decision is referred to as the Principal of Optimization at the Margin.

Answer to Question 2

D




amal

  • Member
  • Posts: 572
Reply 2 on: Jun 29, 2018
Gracias!


ebonylittles

  • Member
  • Posts: 318
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

Earwax has antimicrobial properties that reduce the viability of bacteria and fungus in the human ear.

Did you know?

Patients should never assume they are being given the appropriate drugs. They should make sure they know which drugs are being prescribed, and always double-check that the drugs received match the prescription.

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

Did you know?

More than 2,500 barbiturates have been synthesized. At the height of their popularity, about 50 were marketed for human use.

Did you know?

This year, an estimated 1.4 million Americans will have a new or recurrent heart attack.

For a complete list of videos, visit our video library